🇺🇸 FDA

Intelligence · Clinical Pipeline

R&D Pipeline Programs

ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.

Programs indexed
20,548
Companies
1,769
Drugs tracked
4,797

Quick answer

NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.

1,413 results for “Chinese” Clear

  1. S-ketamine

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Anesthesia

    small molecule active

    1 trial

  2. SCOUT-Assisted Review Workflow

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Coronary Heart Disease (CHD)

    other active

    1 trial

  3. SGLT2 inhibitor

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Kidney Transplantation

    small molecule completed

    1 trial

  4. SSRIs/SNRIs (Selective Serotonin Reuptake Inhibitors/ Serotonin and Norepinephrine Reuptake Inhibitors)

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Major Depressive Disorder

    small molecule active

    1 trial

  5. Salvianolic Acid

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Stroke

    small molecule terminated

    1 trial

  6. Sarcosine Capsule

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Parkinson's Disease With Dementia

    other completed

    1 trial

  7. Sertraline plus placebo of JWXYJN

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Depressive Disorder

    small molecule active

    1 trial

  8. Sheng-Yu-Tang

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Acute Leukemia

    other completed

    1 trial

  9. Simvastatin

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Hyperlipidemias

    small molecule active

    1 trial

  10. Single dose of 2L PEG

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Health Behavior

    small molecule completed

    1 trial

  11. Siwu Tang

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Brain Hypoperfusion Syndrome

    small molecule active

    1 trial

  12. Solifenacin Succinate

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Overactive Bladder

    small molecule active

    1 trial

  13. Spleen Invigorating and Weight Reducing Decoction

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Traditional Chinese Medicine Treatment

    small molecule active

    1 trial

  14. Split dose of 4L PEG

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Health Behavior

    small molecule active

    1 trial

  15. Stereotactic body radiotherapy (SBRT)

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    HSCT

    other active

    1 trial

  16. Study Product A (High-dose 2X)

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Hyperuricemia

    other active

    1 trial

  17. Suanzaoren Decoction and Huanglian Wendan Decoction

    The First People's Hospital of Lianyungang

    Traditional Chinese Medicine

    small molecule active

    1 trial

  18. Subconjunctival dexamethasone and general anesthesia

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Cataract

    small molecule active

    1 trial

  19. Surgery combined with Target-reduction intensity-modulated radiotherapy

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Nasopharyngeal Carcinoma

    other active

    1 trial

  20. Surgery-radiotherapy

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Hepatocellular Carcinoma

    other active

    1 trial

  21. TNK plus standard medical treatment

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Acute Ischemic Stroke

    small molecule active

    1 trial

  22. TPO-RA

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Primary Immune Thrombocytopenic Purpura

    small molecule active

    1 trial

  23. Tacrolimus+Mycophenolate mofetil

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Lupus Nephritis

    small molecule completed

    1 trial

  24. Tadalafil

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Pulmonary Arterial Hypertension (PAH)

    small molecule active

    1 trial

Frequently asked questions

What is the NovaPharmaNews pipeline directory?

It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.

Where does pipeline data come from?

Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.

How do I find pipeline programs by company or phase?

Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.

Data attribution and licensing: Data sources